UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Characterization of acute lymphoblastic leukemia progenitor cells

Blood, 2004-11, Vol.104 (9), p.2919-2925

2004

Link zum Volltext

Verfügbarkeit prüfen

Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial

PloS one, 2014-10, Vol.9 (10), p.e108107-e108107

2014

Link zum Volltext

Verfügbarkeit prüfen

Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol‐E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials

British journal of haematology, 2022-07, Vol.198 (1), p.142-150

2022

Link zum Volltext

Verfügbarkeit prüfen

Activity and toxicity of intramuscular 1000 iu/m 2 polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials

British journal of haematology, 2022-07, Vol.198 (1), p.142-150

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation

Blood reviews, 2005-11, Vol.19 (6), p.289-300

2005

Link zum Volltext

Verfügbarkeit prüfen

Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia

British journal of haematology, 1998-08, Vol.102 (3), p.860-871

1998

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation therapy in children

Paediatric drugs, 2003, Vol.5 (12), p.803-820

2003

Link zum Volltext

Verfügbarkeit prüfen

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia

Blood, 1998-12, Vol.92 (11), p.4072-4079

1998

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia - Prospective Open Cohort Analyses of the ALLR3 Trial: e108107

PloS one, 2014-10, Vol.9 (10)

2014

Link zum Volltext

Verfügbarkeit prüfen

Intensified Conditioning for Children Undergoing BMT for First Bone Marrow Relapse of Acute Lymphoblastic Leukaemia

Blood, 2004-11, Vol.104 (11), p.5169-5169

2004

Link zum Volltext

Verfügbarkeit prüfen

Stem Cells in T-ALL Have a Primitive CD133+/CD34+/CD7- Phenotype

Blood, 2004-11, Vol.104 (11), p.1885-1885

2004

Link zum Volltext

Verfügbarkeit prüfen

CD133 Expression on ALL Progenitor Cells: Further Evidence for a Hierarchy within the Leukaemic Clone

Blood, 2004-11, Vol.104 (11), p.523-523

2004

Link zum Volltext

Verfügbarkeit prüfen

Minimal residual disease analysis for the prediction of relapse in children with standard‐risk acute lymphoblastic leukaemia

British journal of haematology, 1998-01, Vol.100 (1), p.235-244

1998

Link zum Volltext

Verfügbarkeit prüfen

Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia

Journal of clinical oncology, 1998-03, Vol.16 (3), p.931-936

1998

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab (Campath IH) in Conditioning Therapy with Cyclophosphamide and Total Body Irradiation in Matched and Mismatched Unrelated Donor Transplantation of Children with Acute Lymphoblastic Leukaemia: A Report from 3 U.K. Centres

Blood, 2004-11, Vol.104 (11), p.2157-2157

2004

Link zum Volltext

Verfügbarkeit prüfen

CMV Specific Immunotherapy: How Many Patients Will Benefit?

Blood, 2004-11, Vol.104 (11), p.2244-2244

2004

Link zum Volltext

Verfügbarkeit prüfen

Virus‐associated haemophagocytic syndrome: further evidence for a T‐cell mediated disorder

British journal of haematology, 1994-01, Vol.86 (1), p.213-215

1994

Link zum Volltext

Verfügbarkeit prüfen

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

British journal of haematology, 1998-08, Vol.102 (3), p.860-871

1998

Link zum Volltext

Verfügbarkeit prüfen

Oesophageal candidiasis in an HIV-negative individual treated with factor VIII concentrate

Thrombosis and haemostasis, 1992, Vol.68 (6), p.782

1992

Link zum Volltext

Verfügbarkeit prüfen

The salience network is responsible for switching between the default mode network and the central executive network: Replication from DCM

NeuroImage (Orlando, Fla.), 2014-10, Vol.99, p.180-190

2014

Link zum Volltext

Verfügbarkeit prüfen

A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia

Blood, 2014-08, Vol.124 (9), p.1434-1444

2014

Link zum Volltext

Verfügbarkeit prüfen

Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial

Journal of clinical oncology, 2022-12, Vol.40 (36), p.4228-4239

2022

Link zum Volltext

Verfügbarkeit prüfen

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

Blood, 2016-05, Vol.127 (18), p.2214-2218

2016

Link zum Volltext

Verfügbarkeit prüfen

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

Nature medicine, 2019-09, Vol.25 (9), p.1408-1414

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Child
(20)
Female
(20)
Male
(20)
Adolescent
(17)
Child, Preschool
(17)
Hematology
(17)
Biological And Medical Sciences
(14)
Medical Sciences
(13)
Infant
(12)
Adult
(11)
Hematologic And Hematopoietic Diseases
(9)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(7)
Risk Factors
(7)
Transplantation, Homologous
(7)
Oncology
(6)
Prognosis
(6)
Recurrence
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of acute lymphoblastic leukemia progenitor cells

Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial

Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol‐E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials

Activity and toxicity of intramuscular 1000 iu/m 2 polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials

Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation

Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia

Anticoagulation therapy in children

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia - Prospective Open Cohort Analyses of the ALLR3 Trial: e108107

Intensified Conditioning for Children Undergoing BMT for First Bone Marrow Relapse of Acute Lymphoblastic Leukaemia

Stem Cells in T-ALL Have a Primitive CD133+/CD34+/CD7- Phenotype

CD133 Expression on ALL Progenitor Cells: Further Evidence for a Hierarchy within the Leukaemic Clone

Minimal residual disease analysis for the prediction of relapse in children with standard‐risk acute lymphoblastic leukaemia

Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia

Alemtuzumab (Campath IH) in Conditioning Therapy with Cyclophosphamide and Total Body Irradiation in Matched and Mismatched Unrelated Donor Transplantation of Children with Acute Lymphoblastic Leukaemia: A Report from 3 U.K. Centres

CMV Specific Immunotherapy: How Many Patients Will Benefit?

Virus‐associated haemophagocytic syndrome: further evidence for a T‐cell mediated disorder

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

Oesophageal candidiasis in an HIV-negative individual treated with factor VIII concentrate

The salience network is responsible for switching between the default mode network and the central executive network: Replication from DCM

A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia

Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

Suchergebnisse filtern